Photo - AUISET Biotechnology Co Ltd
58695

AUISET Biotechnology Co Ltd

Market: Other
Stage of the project: Operating business

Date of last change: 06.10.2022
Go to the owner's profile
6
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

AUISET specializes in Aggregation-induced Emission solutions, a technology particularly useful in detecting hormone and infertility, and is determined to bring more rapid tests to the market.

Current Status

AUISET has launched its first AIE product in 2020. We have generated HKD $21.2M revenue as of September 2022 and our total sales is expected to reach HKD $28M by the end of 2022. AUISET is primarily focused on AIE research of female hormones, inflammation and cardiac markers and pet diagnostics.

Problem or Opportunity

All traditional fluorescent tags suffer from the Aggregation Caused Quenching (ACQ) phenomenon and cannot proportionally reflect the concentration of marker of interest when the concentration is too high. Besides, most rapid tests in the market, like those with colloidal gold as signal label, have low specificity and cannot provide quantitative measurements to present an accurate result profile.

Solution (product or service)

Aggregation-induced emission (AIE) is an unusual photophysical phenomenon in which luminous efficiency increases as molecules aggregate. AIE – nanoparticles (AIE – NP) carry AIE materials with high stability and many technical advantages. They do not suffer from ACQ phenomenon and are available in different colors and size ranges. They also allow variable surface modifications and have a tunable emission range from visible to near-infrared wavelength. Hence, AIE – NP can be widely used in many biomedical fields to provide highly specific and quantitative results.

Business model

By tapping into the local IVD market through distributing COVID-19 Antigen Rapid Test Kits this year, AUISET has secured a solid financial foundation for supporting further R&D work in multiple biomedical areas and seeking future partnerships.

Incubation/Acceleration programs accomplishment

HKSTP IncuBio Program
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility1083
star0
Add to favorites
Delete from favorites
share
close
thumb_up1
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video
Presentation